- On the catalytic and degradative role of oxygen-containing groups on carbon electrode in non-aqueous ORRPublication without faculty affiliation
- Panitumumab in the treatment of colorectal carcinoma2020 | Publication without faculty affiliation
- Panitumumab as first-line treatment of colorectal cancer2019 | Publication without faculty affiliation
- Efficient Co-N-C electrocatalysts for oxygen reduction derived from deep eutectic solventsPublication without faculty affiliation
- Gram-scale synthesis of alkoxide-derived nitrogen-doped carbon foam as a support for Fe-N-C electrocatalysts2020 | Faculty of Mathematics and Physics
- Defect-Engineered Hydroxylated Mesoporous Spinel Oxides as Bifunctional Electrocatalysts for Oxygen Reduction and Evolution Reactions2022 | Faculty of Mathematics and Physics
- Oxygen Reduction Reaction in Alkaline Media Causes Iron Leaching from Fe-N-C Electrocatalysts2022 | Faculty of Mathematics and Physics
- Evaluation of the MONARCH-2 trial2020 | Faculty of Medicine in Hradec Králové
- Progress in the treatment of cerebral metastases in advanced melanoma2018 | Publication without faculty affiliation
- Osimertinib - a new treatment option for patients with EGFR mutation T790M2017 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Breast cancer surgery after neoadjuvant treatment - the advantages and the disadvantages from surgeon's point of view and the benefits for patients2015 | Publication without faculty affiliation
- Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer2023 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Central Library of Charles University, Third Faculty of Medicine
- Randomizovaná otevřená akademická studie: srovnání standardního podání azacytidinu oproti azacytidinu s preinkubací G-CSF u myelodysplastického syndromu vyššího rizika - interim analýza2019 | First Faculty of Medicine, Faculty of Physical Education and Sport, Faculty of Mathematics and Physics
- Similar efficacy of thalidomide- and bortezomib-based regimens for first relapse of multiple myeloma2011 | First Faculty of Medicine
- Fe-Doping induced divergent growth of Ni-Fe alloy nanoparticles for enhancing the electrocatalytic oxygen reduction2021 | Faculty of Science
- Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma2021 | First Faculty of Medicine
- Phosphorene: A promising metal free cathode material for proton exchange membrane fuel cell2019 | Faculty of Science
- Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial2022 | Second Faculty of Medicine
- Komentář ke studii: Sledování biomarkerů ve studii VELOUR - vliv mutací RAS, BRAF a lokalizace nádoru na účinnost léčby afliberceptem2018 | Publication without faculty affiliation
- Unraveling the Surface Chemistry and Structure in Highly Active Sputtered Pt3Y Catalyst Films for the Oxygen Reduction Reaction2020 | Faculty of Mathematics and Physics
- Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk2021 | First Faculty of Medicine
- Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial2023 | Faculty of Medicine in Hradec Králové
- Surface Composition of a Highly Active Pt3Y Alloy Catalyst for Application in Low Temperature Fuel Cells2020 | Faculty of Mathematics and Physics
- Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study2015 | Faculty of Medicine in Hradec Králové
- Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial2020 | First Faculty of Medicine
- Phase 2 study of parsaclisib (INCB050465), a highly selective, next-generation PI3Kδ inhibitor, in relapsed or refractory diffuse large B-cell lymphoma (CITADEL-202)2021 | Faculty of Medicine in Hradec Králové
- Real-life Effectiveness of Afatinib Versus Gefitinib in Patients With Non-small-cell Lung Cancer: A Czech Multicentre Study2021 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Central Library of Charles University
- Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment2021 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové